TMCnet News

Top Technologies in Health and Wellness 2017: Precision Medicine Advances Likely to Disrupt Existing Cancer Management Landscape in the Future - Research and Markets
[May 22, 2017]

Top Technologies in Health and Wellness 2017: Precision Medicine Advances Likely to Disrupt Existing Cancer Management Landscape in the Future - Research and Markets


Research and Markets has announced the addition of the "Top Technologies in Health and Wellness, 2017" report to their offering.

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Editing and Predictive Biomarkers.

Techvision's professionals have monitored, gathered, and analyzed numerous emerging and disruptive technologies selecting this top 10 technologies, by contacting an extensive network of innovators, technology developers, financial institutions, technologists and researchers, among other players in the ecosystem, with the aim to provide your company or institution with a notable intelligence work that can help you build and implement strong growth strategies by leverage disruptive technologies and emerging innovations.

Key Topics Covered:

1. Executive Summary

2. Precision Oncology

  • Precision Medicine Advances Likely to Disrupt Existing Cancer Management Landscape in the Future
  • Big Pharma Likely to Lead Global Precision Oncology Innovations
  • Precision Oncology Likely to Witness Continued Growth in IP and Funding Activities
  • Precision Medicine Innovations Likely to Transform Global Cancer Management Landscape

3. Molecular Diagnostics

  • Next-geneation Sequencing Technologies Likely to Disrupt Existing Molecular Diagnostic Platforms
  • Emerging Molecular Diagnostic Platforms Present a Growing Market Opportunity
  • US Leads the Patent and Funding Landscape for MDx Innovations
  • Emerging NGS Platforms Likely to Transform Global MDx Landscape


4. Predictive Biomarkers

  • Predictive Biomarker Technologies Lead Personalized Medicine Platforms
  • US Leads the IP Landscape for Predictive Biomarkers
  • Personalized Genomics Start-ups Lead the Venture Landscape
  • Genomic Tests Likely to Lead Biomarker Enabling Platforms

5. Cancer/Tumor Profiling


  • Liquid Biopsy Profiling Platforms Likely to Disrupt Tumor Tissue Biopsy Techniques
  • Tumor Profiling Market Poised for Continued Growth
  • US Leads the IP Landscape for Tumor Profiling
  • Liquid Biopsy Startups Dominate the Venture Landscape
  • Liquid Biopsy Techniques likely to Transform Early Tumor Screening

6. Cellular Therapeutics

  • Stem Cell Therapy is Expected to Address the Most Crucial Medical Challenges
  • The Stem Cell Therapy Field is Very Active In Terms Of New Companies Significantly Impacting the Market by 2021
  • Stem Cells Paving the Way for Precision Medicine Through an Unprecedented Technology Synergy (News - Alert)
  • New Japanese Regulatory Framework Impacting Healthcare Globally

7. Gene Editing

  • Gene Editing Techniques Paving the way for Disease Research and Novel Therapeutics
  • CRISPR-Cas9 Gene Editing Technology Will Significantly Impact the Market by 2021
  • Gene Editing Techniques Paving the Way for Precision Medicine
  • North America and Europe are Dominating the Gene Editing Market

8. Human Microbiomics

  • Microbiomics Impacts Key Consumer Benefit Areas Such as Skin and Gut Health
  • Diversity of Market Potential Provides Multiple Opportunities for Rapid Growth
  • US-based Inventors are Leading in Microbiome-Focused R&D
  • Skincare, GI, and Immunity are Key Consumer Benefit Areas for Microbiome-Focused Products

9. Immune Engineering

  • Immunotherapy Is Pushing the Barriers of Standard Cancer Therapy
  • Replacing Chemotherapy as First-line Treatment Option Increases Revenue Potential of Immunotherapies
  • US-Based Inventors are Leading In Immune-Focused R&D
  • Immuno-oncology Is the Largest Application Segment Present Under Immunotherapy

10. Follow on Biologics: Biobetters

11. Tissue Engineering

For more information about this report visit http://www.researchandmarkets.com/research/jfs2vp/top_technologies


[ Back To TMCnet.com's Homepage ]